Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development (Virtual Training – October 2024)

You are registering to attend PERI’s Cancer education course virtually October 23 – 25, 2024.

Therapeutics for cancer are entering a new era, where precision approaches promise to revolutionize the way in this disease is treated. This comprehensive course reviews current and emerging drugs, immunotherapies, their application to specific cancer types, how to conduct clinical trials for oncologic therapies, and the drug development process for drug candidates leading to their approval. The US Food & and Drug Administration (FDA) regulatory considerations for Oncology drugs, registration endpoints, and accelerated and breakthrough approval mechanisms are also covered.

Please allow up to 24 hours to receive your official course registration confirmation.

Early Registration for this virtual program is availbale through Friday, September 13, 2024.